ArticleReproductive biology and endocrinology : RB&E2026
Testosterone modifies U-Shaped association of eGFR with all-cause mortality in Chinese female centenarians: a prospective cohort study.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundThe relationship between kidney function and mortality in centenarians, particularly with respect to hormonal regulation, remains unclear. This study investigated the association between estimated glomerular filtration rate (eGFR) and all-cause mortality in female centenarians and explored the potential role of testosterone.
methodsWithin the China Hainan Centenarian Cohort Study, 701 female centenarians (median age: 102 years) were enrolled. eGFR was calculated using the CKD-EPI 2009 creatinine equation. Restricted cubic splines (RCSs) and multivariable Cox proportional hazards models were employed to assess nonlinear associations. Likelihood ratio tests were used to evaluate the interaction effect of testosterone.
resultsDuring a median follow-up of 31 months, 643 participants (91.7%) died. RCS analysis revealed a significant nonlinear association (P-overall < 0.001; P-nonlinear = 0.004) between eGFR and all-cause mortality, characterized by a U-shaped curve, with an inflection point of 60.65 mL/min/1.73 m² identified in the adjusted RCS model. Multivariable-adjusted Cox regression analysis showed that each 10-mL/min/1.73 m² increase in eGFR was associated with a 6.8% reduction in all-cause mortality risk (hazard ratio = 0.932, 95% confidence interval: 0.882-0.985, P = 0.012). Compared with centenarians with eGFRs of 45-<60 mL/min/1.73 m², those with eGFRs of ≤ 45 mL/min/1.73 m² had a 44.9% increased risk of all-cause mortality (hazard ratio = 1.449, 95% confidence interval: 1.176-1.785, P < 0.001) and a significantly shorter median survival time (26 months vs. 34 months, P < 0.001). Higher testosterone levels attenuated the association between eGFR and all-cause mortality, indicating a protective effect (P for multivariable nonlinear interaction = 0.022).
conclusionIn female centenarians, lower eGFR (< 45 mL/min/1.73 m²) is independently associated with all-cause mortality, and this association is modified by serum testosterone levels. These findings highlight testosterone as a potential modulator of the kidney function-mortality relationship in centenarians, although the causal relationship requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.